PubMed

Latent Autoimmune Diabetes in Adults.

Naik RG, Brooks-Worrell BM, Palmer JP.

J Clin Endocrinol Metab. 2009 Oct 16. [Epub ahead of print]PMID: 19837918 [PubMed - as supplied by publisher]Related articles

Effects of Exenatide Alone and in Combination With Daclizumab on {beta}-Cell Function in Long-Standing Type 1 Diabetes.

Rother KI, Spain LM, Wesley RA, Digon BJ 3rd, Baron A, Chen K, Nelson P, Dosch HM, Palmer JP, Brooks-Worrell B, Ring M, Harlan DM.

Diabetes Care. 2009 Dec;32(12):2251-7. Epub 2009 Oct 6.PMID: 19808924 [PubMed - in process]Related articles

Challenges in developing endpoints for type 1 diabetes intervention studies.

Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P, Little R, Schloot NC, Leslie RD, Skyler JS, Palmer JP.

Diabetes Metab Res Rev. 2009 Nov;25(8):694-704.PMID: 19771545 [PubMed - in process]Related articles

Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1.

Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, Yu L, Palmer JP, Schatz D, Eisenbarth G; for the Diabetes Prevention Trial–Type 1 Study Group.

Diabetes Care. 2009 Dec;32(12):2269-2274. Epub 2009 Sep 9.PMID: 19741189 [PubMed - as supplied by publisher]Related articles

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2009 Sep;32(9):1603-7. Epub 2009 Jun 1.PMID: 19487644 [PubMed - indexed for MEDLINE]Related articles

Is it time to take a different approach to screening people at high risk for type 1 diabetes?

Boyko EJ, Palmer JP.

Diabetes Care. 2009 May;32(5):966-7. No abstract available. PMID: 19407077 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved T cell assay for identification of type 1 diabetes patients.

Brooks-Worrell B, Warsen A, Palmer JP.

J Immunol Methods. 2009 May 15;344(1):79-83. Epub 2009 Mar 26.PMID: 19328805 [PubMed - indexed for MEDLINE]Related articles

C-peptide in the natural history of type 1 diabetes.

Palmer JP.

Diabetes Metab Res Rev. 2009 May;25(4):325-8. Review.PMID: 19267337 [PubMed - indexed for MEDLINE]Related articles

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.

Mahon JL, Sosenko JM, Rafkin-Mervis L, Krause-Steinrauf H, Lachin JM, Thompson C, Bingley PJ, Bonifacio E, Palmer JP, Eisenbarth GS, Wolfsdorf J, Skyler JS; TrialNet Natural History Committee; Type 1 Diabetes TrialNet Study Group.

Pediatr Diabetes. 2009 Apr;10(2):97-104. Epub 2008 Sep 24.PMID: 18823409 [PubMed - indexed for MEDLINE]Related articles

Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Matheson D, Skyler JS.

Diabetes Care. 2008 Nov;31(11):2188-92. Epub 2008 Jul 23.PMID: 18650369 [PubMed - indexed for MEDLINE]Related articlesFree article

Standardization of C-peptide measurements.

Little RR, Rohlfing CL, Tennill AL, Madsen RW, Polonsky KS, Myers GL, Greenbaum CJ, Palmer JP, Rogatsky E, Stein DT.

Clin Chem. 2008 Jun;54(6):1023-6. Epub 2008 Apr 17.PMID: 18420730 [PubMed - indexed for MEDLINE]Related articlesFree article

A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2008 Mar;31(3):528-33. Epub 2007 Nov 13.PMID: 18000175 [PubMed - indexed for MEDLINE]Related articlesFree article

Tyramine-mediated activation of sympathetic nerves inhibits insulin secretion in humans.

Gilliam LK, Palmer JP, Taborsky GJ Jr.

J Clin Endocrinol Metab. 2007 Oct;92(10):4035-8. Epub 2007 Aug 7.PMID: 17684049 [PubMed - indexed for MEDLINE]Related articlesFree article

Initial treatment with fixed-dose combination rosiglitazone/glimepiride in patients with previously untreated type 2 diabetes.

Chou HS, Palmer JP, Jones AR, Waterhouse B, Ferreira-Cornwell C, Krebs J, Goldstein BJ.

Diabetes Obes Metab. 2008 Aug;10(8):626-37. Epub 2007 Jul 21.PMID: 17645558 [PubMed - indexed for MEDLINE]Related articles

Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects.

Jensen RA, Gilliam LK, Törn C, Landin-Olsson M, Karlsson FA, Palmer JP, Kockum I, Akesson K, Lernmark B, Lynch K, Breslow N, Lernmark A; Diabetes Incidence Study in Sweden (DISS) group.

J Diabetes Complications. 2007 Jul-Aug;21(4):205-13.PMID: 17616349 [PubMed - indexed for MEDLINE]Related articles

Role of insulin resistance in predicting progression to type 1 diabetes.

Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2007 Sep;30(9):2314-20. Epub 2007 May 29.PMID: 17536068 [PubMed - indexed for MEDLINE]Related articlesFree article

T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.

Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B.

Diabetes. 2007 Aug;56(8):2110-5. Epub 2007 May 1.PMID: 17473222 [PubMed - indexed for MEDLINE]Related articlesFree article

Host immune competence and local ischemia affects the functionality of engineered vasculature.

Chen RR, Snow JK, Palmer JP, Lin AS, Duvall CL, Guldberg RE, Mooney DJ.

Microcirculation. 2007 Feb;14(2):77-88.PMID: 17365663 [PubMed - indexed for MEDLINE]Related articles

International comparison of C-peptide measurements.

Wiedmeyer HM, Polonsky KS, Myers GL, Little RR, Greenbaum CJ, Goldstein DE, Palmer JP.

Clin Chem. 2007 Apr;53(4):784-7. Epub 2007 Mar 1.PMID: 17332147 [PubMed - indexed for MEDLINE]Related articlesFree article

Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.

Chiu HK, Tsai EC, Juneja R, Stoever J, Brooks-Worrell B, Goel A, Palmer JP.

Diabetes Res Clin Pract. 2007 Aug;77(2):237-44. Epub 2007 Jan 17.PMID: 17234296 [PubMed - indexed for MEDLINE]Related articles

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2007 Jan;30(1):38-42.PMID: 17192330 [PubMed - indexed for MEDLINE]Related articlesFree article

How useful is autoantibody screening in adult-onset diabetes?

Gilliam LK, Palmer JP.

Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):490-1. No abstract available. PMID: 16957761 [PubMed]Related articles

Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study.

Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC.

Diabetes. 2006 Sep;55(9):2588-94.PMID: 16936208 [PubMed - indexed for MEDLINE]Related articlesFree article

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS.

Diabetes Care. 2006 Mar;29(3):643-9.PMID: 16505520 [PubMed - indexed for MEDLINE]Related articlesFree article

Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes.

Redondo MJ, Babu S, Zeidler A, Orban T, Yu L, Greenbaum C, Palmer JP, Cuthbertson D, Eisenbarth GS, Krischer JP, Schatz D; Diabetes Prevention Trial Type 1 Study Group.

J Clin Endocrinol Metab. 2006 May;91(5):1705-13. Epub 2006 Feb 7.PMID: 16464953 [PubMed - indexed for MEDLINE]Related articlesFree article

The rise and fall of insulin secretion in type 1 diabetes mellitus.

Tsai EB, Sherry NA, Palmer JP, Herold KC.

Diabetologia. 2006 Feb;49(2):261-70. Epub 2006 Jan 11. Review.PMID: 16404554 [PubMed - indexed for MEDLINE]Related articles

Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?

Palmer JP, Hampe CS, Chiu H, Goel A, Brooks-Worrell BM.

Diabetes. 2005 Dec;54 Suppl 2:S62-7. Review.PMID: 16306342 [PubMed - indexed for MEDLINE]Related articlesFree article

Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes.

Gilliam LK, Brooks-Worrell BM, Palmer JP, Greenbaum CJ, Pihoker C.

J Autoimmun. 2005 Nov;25(3):244-50. Epub 2005 Oct 21.PMID: 16243484 [PubMed - indexed for MEDLINE]Related articles

Latent autoimmune diabetes in adults (LADA) should be less latent.

Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC.

Diabetologia. 2005 Nov;48(11):2206-12. Epub 2005 Sep 29. Review.PMID: 16193284 [PubMed - indexed for MEDLINE]Related articles

Therapeutic targets for the prevention of type 1 diabetes mellitus.

Singh N, Palmer JP.

Curr Drug Targets Immune Endocr Metabol Disord. 2005 Jun;5(2):227-36. Review.PMID: 16089357 [PubMed - indexed for MEDLINE]Related articles

Epitope analysis of insulin autoantibodies using recombinant Fab.

Padoa CJ, Crowther NJ, Thomas JW, Hall TR, Bekris LM, Torn C, Landin-Olsson M, Ortqvist E, Palmer JP, Lernmark A, Hampe CS.

Clin Exp Immunol. 2005 Jun;140(3):564-71.PMID: 15932520 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum.

Villahermosa LG, Fajardo TT Jr, Abalos RM, Balagon MV, Tan EV, Cellona RV, Palmer JP, Wittes J, Thomas SD, Kook KA, Walsh GP, Walsh DS.

Am J Trop Med Hyg. 2005 May;72(5):518-26.PMID: 15891124 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E.

Diabetes Care. 2005 May;28(5):1068-76.PMID: 15855569 [PubMed - indexed for MEDLINE]Related articlesFree article

Autoimmune diabetes: more than just one flavor?

Chiu HK, Palmer JP.

J Endocrinol Invest. 2004 May;27(5):480-4. Review. No abstract available. PMID: 15279084 [PubMed - indexed for MEDLINE]Related articles

Precursor frequencies of T-cells reactive to insulin in recent onset type 1 diabetes mellitus.

Naik RG, Beckers C, Wentwoord R, Frenken A, Duinkerken G, Brooks-Worrell B, Schloot NC, Palmer JP, Roep BO.

J Autoimmun. 2004 Aug;23(1):55-61.PMID: 15236753 [PubMed - indexed for MEDLINE]Related articles

Autoimmunity to islet proteins in children diagnosed with new-onset diabetes.

Brooks-Worrell BM, Greenbaum CJ, Palmer JP, Pihoker C.

J Clin Endocrinol Metab. 2004 May;89(5):2222-7.PMID: 15126545 [PubMed - indexed for MEDLINE]Related articlesFree article

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW.

Diabetes. 2004 Jan;53(1):250-64. Erratum in: Diabetes. 2004 Jul;53(7):1934. PMID: 14693724 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.

Purnell JQ, Dev RK, Steffes MW, Cleary PA, Palmer JP, Hirsch IB, Hokanson JE, Brunzell JD.

Diabetes. 2003 Oct;52(10):2623-9.PMID: 14514648 [PubMed - indexed for MEDLINE]Related articlesFree article

Latent autoimmune diabetes in adults (LADA).

Naik RG, Palmer JP.

Rev Endocr Metab Disord. 2003 Sep;4(3):233-41. Review. No abstract available. PMID: 14501174 [PubMed - indexed for MEDLINE]Related articles

Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes.

Sibley SD, Palmer JP, Hirsch IB, Brunzell JD.

J Clin Endocrinol Metab. 2003 Jul;88(7):3379-84.PMID: 12843191 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).

Cheung MC, Sibley SD, Palmer JP, Oram JF, Brunzell JD.

J Lipid Res. 2003 Aug;44(8):1552-8. Epub 2003 Jun 1.PMID: 12777470 [PubMed - indexed for MEDLINE]Related articlesFree article

What's in a name: latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes.

Palmer JP, Hirsch IB.

Diabetes Care. 2003 Feb;26(2):536-8. No abstract available. PMID: 12547896 [PubMed - indexed for MEDLINE]Related articlesFree article

Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.

Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS.

J Clin Endocrinol Metab. 2003 Jan;88(1):103-8.PMID: 12519837 [PubMed - indexed for MEDLINE]Related articlesFree article

Manipulating the type 1 diabetes disease process, man versus mouse.

Palmer JP.

Diabetes Care. 2002 Jul;25(7):1240-1. No abstract available. PMID: 12087026 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhaled insulin and insulin antibodies: a new twist to an old debate.

Stoever JA, Palmer JP.

Diabetes Technol Ther. 2002;4(2):157-61. Review.PMID: 12079619 [PubMed - indexed for MEDLINE]Related articles

Beta cell rest and recovery--does it bring patients with latent autoimmune diabetes in adults to euglycemia?

Palmer JP.

Ann N Y Acad Sci. 2002 Apr;958:89-98. Review.PMID: 12021087 [PubMed - indexed for MEDLINE]Related articles

Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes.

Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohmé G; Diabetes Incidence in Sweden Study Group; Swedish Childhood Diabetes Study Group.

Diabetes. 2002 May;51(5):1346-55.PMID: 11978629 [PubMed - indexed for MEDLINE]Related articlesFree article

Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study.

LaGasse JM, Brantley MS, Leech NJ, Rowe RE, Monks S, Palmer JP, Nepom GT, McCulloch DK, Hagopian WA; Washingtno State Diabetes Prediction Study.

Diabetes Care. 2002 Mar;25(3):505-11.PMID: 11874938 [PubMed - indexed for MEDLINE]Related articlesFree article

Islet cell autoimmunity and mitochondrial DNA mutation in Korean subjects with typical and atypical Type I diabetes.

Lee WJ, Lee HW, Palmer JP, Park KS, Lee HK, Park JY, Hong SK, Lee KU.

Diabetologia. 2001 Dec;44(12):2187-91.PMID: 11793020 [PubMed - indexed for MEDLINE]Related articles

Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.

Juneja R, Hirsch IB, Naik RG, Brooks-Worrell BM, Greenbaum CJ, Palmer JP.

Metabolism. 2001 Sep;50(9):1008-13.PMID: 11555830 [PubMed - indexed for MEDLINE]Related articles